Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19.
Adv Chronic Kidney Dis
; 27(5): 365-376, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-975047
ABSTRACT
Acute kidney injury (AKI) is common among hospitalized patients with Coronavirus Infectious Disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. The variability in the occurrence of AKI has been attributed to the difference in geographic locations, race/ethnicity, and severity of illness. AKI among hospitalized patients is associated with increased length of stay and in-hospital deaths. Even patients with AKI who survive to hospital discharge are at risk of developing chronic kidney disease or end-stage kidney disease. An improved knowledge of the pathophysiology of AKI in COVID-19 is crucial to mitigate and manage AKI and to improve the survival of patients who developed AKI during COVID-19. The goal of this article is to provide our current understanding of the etiology and the pathophysiology of AKI in the setting of COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cytokines
/
Thrombotic Microangiopathies
/
Acute Kidney Injury
/
COVID-19
/
Glomerulonephritis
Type of study:
Etiology study
/
Prognostic study
Language:
English
Journal:
Adv Chronic Kidney Dis
Journal subject:
Nephrology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS